Current Protein Identity:Q495A1 New Search
Main Difference Dimensions in This Set
Different construct Different mutation/modification Different assembly state Different ligand/ion Different experimental conditions Different structure-quality metrics

Difference tags compare only the current result set; every original PDB and assembly record remains separate.

Related-Structure Differences

Each row represents one biological assembly in one PDB entry; multiple monomers of the same protein are listed separately.

PDB Entry Assembly / Oligomeric State Construct Mutations and Modifications Ligands, Ions and Non-polymers Experimental Method Experimental Conditions Structure Quality
3Q0H Structure of T-cell immunoreceptor with immunoglobulin and ITIM domains (TIGIT) Deposited 2010-12-15 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 22–137(116 aa) Fragment:Ig-like V-type domain residues 22-137
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 6;298 K;1.3M Ammonium Sulfate, 0.1M MES pH 6.0, Vapor diffusion, Sitting drop, temperature 298K
Resolution 1.70 Å R-free 0.237
3Q0H Structure of T-cell immunoreceptor with immunoglobulin and ITIM domains (TIGIT) Deposited 2010-12-15 Assembly 2 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain B 22–137(116 aa) Fragment:Ig-like V-type domain residues 22-137
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 6;298 K;1.3M Ammonium Sulfate, 0.1M MES pH 6.0, Vapor diffusion, Sitting drop, temperature 298K
Resolution 1.70 Å R-free 0.237
3RQ3 Structure of T-cell immunoreceptor with immunoglobulin and ITIM domains (TIGIT) in hexagonal crystal form Deposited 2011-04-27 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 22–137(116 aa) Fragment:UNP residues 22-137
Chain B 22–137(116 aa) Fragment:UNP residues 22-137
Not recorded CL CHLORIDE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 5.5;298 K;1.0M Ammonium Sulfate, 0.1M BIS-TRIS pH 5.5, 1% PEG3350, Vapor diffusion, Sitting drop, temperature 298K
Resolution 2.70 Å R-free 0.253
3UCR Crystal structure of the immunoreceptor TIGIT IgV domain Deposited 2011-10-27 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 23–128(106 aa) Fragment:UNP residues 23-128
Chain C 23–128(106 aa) Fragment:UNP residues 23-128
Not recorded CL CHLORIDE ION × 4 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 7.5;298 K;1.5 M (NH4)2SO4 and 0.1M HEPES pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K
Resolution 2.63 Å R-free 0.274
3UCR Crystal structure of the immunoreceptor TIGIT IgV domain Deposited 2011-10-27 Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain B 23–128(106 aa) Fragment:UNP residues 23-128
Chain D 23–128(106 aa) Fragment:UNP residues 23-128
Not recorded CL CHLORIDE ION × 4 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 7.5;298 K;1.5 M (NH4)2SO4 and 0.1M HEPES pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K
Resolution 2.63 Å R-free 0.274
3UDW Crystal structure of the immunoreceptor TIGIT in complex with Poliovirus receptor (PVR/CD155/necl-5) D1 domain Deposited 2011-10-28 Assembly 1 Protein heterocomplex Heteromer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain A 20–128(109 aa) Fragment:TIGIT, UNP residues 20-128
Chain B 20–128(109 aa) Fragment:TIGIT, UNP residues 20-128
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 4 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 5.5;298 K;0.1 M Ammonium acetate 0.1 M Bis-Tris pH 5.5 17% PEG 10000, VAPOR DIFFUSION, HANGING DROP, temperature 298K
Resolution 2.90 Å R-free 0.287
5V52 Structure of TIGIT bound to nectin-2 (CD112) Deposited 2017-03-13 Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 22–128(107 aa)
Not recorded GOL GLYCEROL × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;293 K;1.3 M Lithium Sulfate 0.1M Tris ph7
Resolution 3.10 Å R-free 0.236
5V52 Structure of TIGIT bound to nectin-2 (CD112) Deposited 2017-03-13 Assembly 2 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain B 22–128(107 aa)
Not recorded SO4 SULFATE ION × 1 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;293 K;1.3 M Lithium Sulfate 0.1M Tris ph7
Resolution 3.10 Å R-free 0.236
7VYT Crystal structure of human TIGIT(23-129) in complex with the scFv fragment of anti-TIGIT antibody MG1131 Deposited 2021-11-15 Assembly 1 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric(3) Consistent with protein count
Chain A 23–129(107 aa)
Not recorded FLC CITRATE ANION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;293.15 K;200mM ammonium citrate, 20% (v/v) polyethylene glycol 3350
Resolution 1.53 Å R-free 0.219
7VYT Crystal structure of human TIGIT(23-129) in complex with the scFv fragment of anti-TIGIT antibody MG1131 Deposited 2021-11-15 Assembly 2 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric(3) Consistent with protein count
Chain T 23–129(107 aa)
Not recorded FLC CITRATE ANION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;293.15 K;200mM ammonium citrate, 20% (v/v) polyethylene glycol 3350
Resolution 1.53 Å R-free 0.219
8JEL Crystal structure of TIGIT in complexed with Ociperlimab, crystal form I Deposited 2023-05-16 Assembly 1 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric(3) Consistent with protein count
Chain J 22–128(107 aa)
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;293 K;0.1 M citric acid pH 4.6, 1 M lithium chloride, 7% PEG6000
Resolution 2.45 Å R-free 0.249
8JEL Crystal structure of TIGIT in complexed with Ociperlimab, crystal form I Deposited 2023-05-16 Assembly 2 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric(3) Consistent with protein count
Chain E 22–128(107 aa)
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;293 K;0.1 M citric acid pH 4.6, 1 M lithium chloride, 7% PEG6000
Resolution 2.45 Å R-free 0.249
8JEL Crystal structure of TIGIT in complexed with Ociperlimab, crystal form I Deposited 2023-05-16 Assembly 3 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric(3) Consistent with protein count
Chain H 22–128(107 aa)
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;293 K;0.1 M citric acid pH 4.6, 1 M lithium chloride, 7% PEG6000
Resolution 2.45 Å R-free 0.249
8JEL Crystal structure of TIGIT in complexed with Ociperlimab, crystal form I Deposited 2023-05-16 Assembly 4 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric(3) Consistent with protein count
Chain L 22–128(107 aa)
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;293 K;0.1 M citric acid pH 4.6, 1 M lithium chloride, 7% PEG6000
Resolution 2.45 Å R-free 0.249
8JEN Crystal structure of TIGIT in complexed with Ociperlimab, crystal form II Deposited 2023-05-16 Assembly 1 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric(3) Consistent with protein count
Chain I 22–128(107 aa)
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;293 K;0.1 M sodium citrate tribasic dihydrate pH 5.2, 17% PEG 20000
Resolution 2.71 Å R-free 0.289
8JEN Crystal structure of TIGIT in complexed with Ociperlimab, crystal form II Deposited 2023-05-16 Assembly 2 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric(3) Consistent with protein count
Chain J 22–128(107 aa)
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;293 K;0.1 M sodium citrate tribasic dihydrate pH 5.2, 17% PEG 20000
Resolution 2.71 Å R-free 0.289
8JEN Crystal structure of TIGIT in complexed with Ociperlimab, crystal form II Deposited 2023-05-16 Assembly 3 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric(3) Consistent with protein count
Chain M 22–128(107 aa)
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;293 K;0.1 M sodium citrate tribasic dihydrate pH 5.2, 17% PEG 20000
Resolution 2.71 Å R-free 0.289
8JEN Crystal structure of TIGIT in complexed with Ociperlimab, crystal form II Deposited 2023-05-16 Assembly 4 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric(3) Consistent with protein count
Chain P 22–128(107 aa)
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;293 K;0.1 M sodium citrate tribasic dihydrate pH 5.2, 17% PEG 20000
Resolution 2.71 Å R-free 0.289
8JEO Crystal structure of TIGIT in complexed with Tiragolumab Deposited 2023-05-16 Assembly 1 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric(3) Consistent with protein count
Chain A 22–128(107 aa)
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;293 K;0.1 M ammonium citrate tribasic pH 7.4, 14% PEG 3350
Resolution 2.06 Å R-free 0.205
8JEO Crystal structure of TIGIT in complexed with Tiragolumab Deposited 2023-05-16 Assembly 2 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric(3) Consistent with protein count
Chain D 22–128(107 aa)
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;293 K;0.1 M ammonium citrate tribasic pH 7.4, 14% PEG 3350
Resolution 2.06 Å R-free 0.205
8SZY Crystal Structure of Heterotrimeric Anti-TIGIT Fabs in complex with human TIGIT Deposited 2023-05-30 Assembly 1 Protein heterocomplex Heteromer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain T 23–128(106 aa)
Mutation:C69S NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;300 K;0.2 M sodium phosphate monobasic monohydrate, 20% w/v Polyethylene glycol 1,000
Resolution 2.31 Å R-free 0.269
8SZY Crystal Structure of Heterotrimeric Anti-TIGIT Fabs in complex with human TIGIT Deposited 2023-05-30 Assembly 2 Protein heterocomplex Heteromer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain U 23–128(106 aa)
Mutation:C69S NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;300 K;0.2 M sodium phosphate monobasic monohydrate, 20% w/v Polyethylene glycol 1,000
Resolution 2.31 Å R-free 0.269
8VTD Co-structure of the Fab of the anti-TIGIT Vibostolimab antibody with its antigen Deposited 2024-01-26 Assembly 1 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric(3) Consistent with protein count
Chain C 22–137(116 aa)
Not recorded GOL GLYCEROL × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;300 K;16% w/v PEG 20K
Resolution 1.23 Å R-free 0.204
8VTE Co-structure of the Fab of the anti-TIGIT Vibostolimab antibody with its antigen Deposited 2024-01-26 Assembly 1 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric(3) Consistent with protein count
Chain E 22–137(116 aa)
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 6.5;300 K;0.02M D-Glucose; 0.02M D-Mannose; 0.02M D-Galactose; 0.02M L-Fucose; 0.02M D-Xylose; 0.02M N-Acetyl-D-Glucosamine; 0.1M Imidazole, 0.1M MES; 20%v/v Glycerol; 10% PEG4K
Resolution 2.29 Å R-free 0.268
8VTE Co-structure of the Fab of the anti-TIGIT Vibostolimab antibody with its antigen Deposited 2024-01-26 Assembly 2 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric(3) Consistent with protein count
Chain F 22–137(116 aa)
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 6.5;300 K;0.02M D-Glucose; 0.02M D-Mannose; 0.02M D-Galactose; 0.02M L-Fucose; 0.02M D-Xylose; 0.02M N-Acetyl-D-Glucosamine; 0.1M Imidazole, 0.1M MES; 20%v/v Glycerol; 10% PEG4K
Resolution 2.29 Å R-free 0.268